Nikolaos Mellios

Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023.

Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023.

Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023.

Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023.

Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023.